Dataset Information


In vitro comparison of hydroxocobalamin (B12a) and the mitochondrial directed therapy by a succinate prodrug in a cellular model of cyanide poisoning

ABSTRACT: Graphical abstract Highlights • Cyanide is a cytochrome c oxidase inhibitor that results in bioenergetic failure.• There is a cell-permeable succinate prodrug, NV118, that releases succinate.• Our mitochondrial-directed therapy (NV118) but not B12a improved cellular function.• There was attenuation of ROS with NV118 but not with B12a treatment. The objective of this study was to compare the use of hydroxocobalamin (B12a) and a succinate prodrug to evaluate for improvement in mitochondrial function in an in vitro model of cyanide poisoning. Peripheral blood mononuclear cells (PBMC) and human aortic smooth muscle cells (HASMC) incubated with 50?mM of sodium cyanide (CN) for five minutes serving as the CN group compared to controls. We investigated the following: (1) Mitochondrial respiration; (2) Superoxide and mitochondrial membrane potential with microscopy; (3) Citrate synthase protein expression. All experiments were performed with a cell concentration of 2?3?×?106 cells/ml for both PBMC and HASMC. There were four conditions: (1) Control (no exposure); (2) Cyanide (exposure only); (3) B12a (cyanide exposure followed by B12a treatment); (4) NV118 (cyanide followed by NV118 treatment). In this study the key findings include: (1) Improvement in key mitochondrial respiratory states with the succinate prodrug (NV118) but not B12a; (2) Attenuation of superoxide production with treatment of NV118 but not with B12a treatment; (3) The changes in respiration were not secondary to increased mitochondrial content as measured by citrate synthase; (4) The use of easily accessible human blood cells showed similar mitochondrial response to both cyanide and treatment to HASMC. The use of a succinate prodrug to circumvent partial CIV inhibition by cyanide with clear reversal of cellular respiration and superoxide production that was not attributed to changes in mitochondrial content not seen by the use of B12a.


PROVIDER: S-EPMC7511654 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC6070446 | BioStudies
2016-01-01 | S-EPMC4980488 | BioStudies
1979-01-01 | S-EPMC1161685 | BioStudies
2020-01-01 | S-EPMC7135280 | BioStudies
1967-01-01 | S-EPMC1270446 | BioStudies
2013-01-01 | S-EPMC3536694 | BioStudies
2003-01-01 | S-EPMC152980 | BioStudies
1000-01-01 | S-EPMC5983469 | BioStudies
2018-01-01 | S-EPMC6314144 | BioStudies
1974-01-01 | S-EPMC1168532 | BioStudies